Accelerating the development of targeted neuromodulation therapies

The first phase called on scientists, engineers, and clinicians to submit novel concepts and plans for development.

Neuromod Prize

About the competition

The Neuromod Prize is a SPARC (Stimulating Peripheral Activity to Relieve Conditions) initiative from the National Institutes of Health (NIH) Common Fund. The competition seeks groundbreaking uses of peripheral nerve stimulation that can independently regulate two or more desired autonomic functions without unintended effects on non-target organs. At the discretion of NIH, additional competition phases may follow Phase 1.


Phase 1

Open to all eligible participants

Participants submitted concept papers describing their proposed therapeutic approach and plans for conducting proof-of-concept studies. They are competing for a share of the total prize pool.


Phase 2

Open to winners of Phase 1

Up to eight Phase 1 winners will exclusively be invited to develop proof-of-concept studies and compete for a share of the total prize pool.



Phase 3

Open to winners of Phase 2

Up to four Phase 2 winners may subsequently be selected to conduct IDE-enabling studies and compete for a share of the total prize pool.


Phase 1 prize

judging panel will select up to eight winners according to official Phase 1 judging criteria. Phase 1 winners will receive a share of the Phase 1 prize pool (up to $800,000) and the opportunity to participate in a planned Phase 2.


With $9.8 million total prize pool planned across three phases

Phase 1 timeline

Submission period

January 18 - April 28, 2022

Virtual information session

February 7, 2022

Technical considerations panel

March 9, 2022

Submission deadline

April 28, 2022
We are here


May - June 2022

Phase 1 winner announcement

June 2022

Phase 2 launch

Late summer 2022
The submission period for Phase 1 is now closed.